http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107982252-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 |
| filingDate | 2017-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107982252-B |
| titleOfInvention | Application of traditional Chinese medicine composition in Japanese encephalitis |
| abstract | The present invention relates to the application of ginkgolide composition in preparing medicine for treating Japanese encephalitis. The in vitro experiments of the present invention show that the ginkgolide composition can inhibit JEV-infected BHK-21 cytopathies. In addition, after administration of the composition, the neurobehavioral symptoms of suckling mice can be significantly improved, and the volume and water content of the infected area are reduced to varying degrees. In addition, the ginkgolide composition can dose-dependently reduce the expression of TNF-α and IL-2 in brain tissue. Therefore, the present invention confirms that the ginkgolide composition has the effect of treating/preventing Japanese encephalitis. |
| priorityDate | 2017-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 92.